1. Ritch R, Liebmann JM, Tello C. A construct for understanding angle-closure glaucoma: the role of ultrasound biomicroscopy. Ophthalmol Clin North Am. 1995;8:281-293.

2. Feitl ME, Krupin T. Hyperosmotic agents. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. St Louis, MO: CV Mosby; 1996.

3. Drance SM. Effect of oral glycerol on intraocular pressure in normal and glaucomatous eyes. Arch Ophthalmol. 1964;72:491.

4. Oakley DE, Ellis PP. Glycerol and hyperosmolar nonketotic coma. Am J Ophthalmol. 1976;81:469.

5. Almog Y, Geyer O, Laser M. Pulmonary edema as a complication of oral glycerol administration. Ann Ophthalmol. 1986;18:38.

6. Ritch R. The pilocarpine paradox. J Glaucoma. 1996;5:225-227.

7. Ganias F, Mapstone R. Miotics in closed-angle glaucoma. Br J Ophthalmol. 1975; 59:205.

8. Airaksinen PJ, Saari KM, Tiainen TJ, et al. Management of acute closed-angle glaucoma with miotics and timolol. Br J Ophthalmol. 1979;63:822.

9. Kramer P, Ritch R. The treatment of angle-closure glaucoma revisited [editorial]. Ann Ophthalmol. 1984;16:1101-1103.

10. Ritch R. Argon laser treatment for medically unresponsive attacks of angle-closure glaucoma. Am J Ophthalmol. 1982;94:197.

11. Ritch R, Liebmann JM. Argon laser peripheral iridoplasty: a review. Ophthalmic Surg Lasers. 1996;27:289-300.

12. Tham CCY, Lai JSM, Poon ASY, et al. Immediate argon laser peripheral iridoplasty (ALPI) as initial treatment for acute phacomorphic angle-closure (phacomorphic glaucoma) before cataract extraction: a preliminary study. Eye. 2005;19:778-783.

13. Lai JSM, Tham CCY, Chua JKH, et al. Laser peripheral iridoplasty as initial treatment of acute attack of primary angle-closure: a long-term follow-up study. J Glaucoma. 2002;11:484-487.

14. Lam DSC, Lai JSM, Tham CCY. Immediate argon laser peripheral iridoplasty as treatment for acute attack of primary angle-closure glaucoma. A preliminary study. Ophthalmology. 1998;105:2231-2236.

15. Yip PPW, Leung WY, Hon CY, Ho CK. Argon laser peripheral iridoplasty in the management of phacomorphic glaucoma. Ophthalmic Surg Lasers Imaging. 2005;36: 286-291.

16. Chew PT, Aung T, Aquino MV, Rojanapongpun P; EXACT Study Group. Intraocular pressure-reducing effects and safety of latanoprost versus timolol in patients with chronic angle-closure glaucoma. Ophthalmology. 2004;111:427-434.

Aung T, Chan YH, Chew PT; EXACT Study Group. Degree of angle closure and intraocular pressure-lowering effect of latanoprost in subjects with chronic angle-closure glaucoma. Ophthalmology. 2005;112:267-271.

Sihota R, Saxena R, Agarwal HC, Gulati V. Cross-over comparison of timolol and latanoprost in chronic primary angle-closure glaucoma. Arch Ophthalmol. 2004;122: 185-189.

Kook MS, Cho HS, Yang SJ, et al. Efficacy of latanoprost in patients with chronic angle-closure glaucoma and no visible ciliary-body face: a preliminary study. J Ocul Pharmacol Ther. 2005;21:75-84.

Shirakashi M, Iwata K, Nakayama T. Argon laser trabeculoplasty for chronic angle-closure glaucoma uncontrolled by iridotomy. Acta Ophthalmol. 1989;67:265-270. Wishart PK, Nagasubramanian S, Hitchings RA. Argon laser trabeculoplasty in narrow angle glaucoma. Eye. 1987;1:567.

Eltz H, Gloor B. Trabeculectomy in cases of angle-closure glaucoma—successes and failures. Klin Monatsbl Augenheilkd. 1980;177:556-561.

Shields MD, Ritch R, Krupin TK. Classifications and mechanisms of the glaucomas. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. St Louis, MO: CV Mosby; 1996. Liebmann JM, Tello C, Chew S-J, Cohen H, Ritch R. Prevention of blinking alters iris configuration in pigment dispersion syndrome and in normal eyes. Ophthalmology. 1995;102:446-455.

Karickhoff JR. Reverse pupillary block in pigmentary glaucoma: follow up and new developments. Ophthalmic Surg. 1993;24:562-563.

Adam RS, Pavlin CJ, Ulanski LJ. Ultrasound biomicroscopic analysis of iris profile changes with accommodation in pigmentary glaucoma and relationship to age. Am J Ophthalmol. 2004;138:652-654.

Heys JJ, Barocas VH. Computational evaluation of the role of accommodation in pigmentary glaucoma. Invest Ophthalmol Vis Sci. 2002;43:700-708. Ritch R, Liebmann J, Tello C, Chew SJ. Ultrasound biomicroscopic findings in pigment dispersion syndrome. In: Krieglstein GK, ed. Glaucoma Update V. Heidelberg: Kaden Verlag; 1995.

Scheie HG, Cameron JD. Pigment dispersion syndrome: a clinical study. Br J Ophthalmol. 1981;65:264-269.

Weseley P, Liebmann J, Walsh JB, Ritch R. Lattice degeneration of the retina and the pigment dispersion syndrome. Am J Ophthalmol. 1992;114:539-543. Becker B. Does hyposecretion of aqueous humor damage the trabecular meshwork? [editorial]. J Glaucoma. 1995;4:303-305.

Mastropasqua L, Carpineto P, Ciancaglini M, Gallenga PE. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma. Ophthalmology. 1999;106:550-555.

Becker B, Shin DH, Cooper DG, Kass MA. The pigment dispersion syndrome. Am J Ophthalmol. 1977;83:161-166.

Ritch R. A unification hypothesis of pigment dispersion syndrome. Trans Am Oph-thalmolSoc. 1996;94:381-409.

Haynes WL, Alward WLM, Tello C, Liebmann JM, Ritch R. Incomplete elimination of exercise-induced pigment dispersion by laser iridotomy in pigment dispersion syndrome. Ophthalmic Surg Lasers. 1995;26:484-486.

Haynes WL, Johnson AT, Alward WLM. Incomplete elimination of exercise-induced pigment dispersion in a patient with the pigment dispersion syndrome. Am J Oph-thalmol. 1990;109:599-601.

37. Reistad E, Shields MB, Campbell DG, et al. The influence of peripheral iridotomy on the intraocular pressure course in patients with pigmentary glaucoma. J Glaucoma. 2005;14:255-259.

38. Ritch R, Schlotzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45: 265-315.

39. Grodum K, Heijl A, Bengtsson B. Risk of glaucoma in ocular hypertension with and without pseudoexfoliation. Ophthalmology. 2005;112:386-390.

40. Konstas AG, Mylopoulos N, Karabatsas CH. Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma. Eye. 2004;18:893-899.

41. Konstas AGP, Kozobolis VP, Tersis I, Leech J, Stewart WC. The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma. Eye. 2003;17:41-46.

42. Mapstone R. Pigment release. Br J Ophthalmol. 1981;65:258-263.

43. Shaw BR, Lewis RA. Intraocular pressure elevation after pupillary dilation in open angle glaucoma. Arch Ophthalmol. 1986;104:1185-1188.

44. Zugerman C, Saunders D, Levit F. Glaucoma from topically applied steroids. Arch Dermatol. 1976;112:1326.

45. Cubey RB. Glaucoma following the application of corticosteroid to the skin of the eyelid. Br J Dermatol. 1976;95;207.

46. Garbe E, LeLorier J, Bolvin J-F, Suissa S. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA. 1997;277:722-727.

47. Haas JS, Nootens RH. Glaucoma secondary to benign adrenal adenoma. Am J Ophthalmol. 1974;78:497.

48. Kass MA, Johnson T. Corticosteroid-induced glaucoma. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. St Louis, MO: CV Mosby Co; 1989.

49. Weinreb RN, et al. Acute effects of dexamethesone on intraocular pressure in glaucoma. Invest Ophthalmol Vis Sci. 1985;26:170.

50. Kass MA, Kolker AE, Becker B. Chronic topical corticosteroid use simulating congenital glaucoma. J Pediatr. 1972;81:1175.

51. Jonas JB, Degenring RF, Kreissig I, et al. Intraocular pressure elevation after in-travitreal triamcinolone acetonide injection. Ophthalmology. 2005;112:593-598.

52. Diabetes Control, Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.

53. Goldberg MF. The diagnosis and treatment of sickled erythrocytes in human hyphe-mas. Trans Am Ophthalmol Soc. 1978;76:481.

54. Herschler J. Trabecular damage due to blunt anterior segment injury and its relationship to traumatic glaucoma. Trans Am Acad Ophthalmol Otol. 1977;83:OP239.

55. Mermoud A, et al. Surgical management of post-traumatic angle recession glaucoma. Ophthalmology. 1993;100:634.

56. Rosenbaum JT, Tammaro J, Robertson JE Jr. Uveitis precipitated by nonpenetrating ocular trauma. Am J Ophthalmol. 1991;112:392.

57. Bowman RJC, Cope J, Nischal KK. Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan) in children. Eye. 2004;18:24-26.

58. Kurtz S, Shemesh G. The efficacy and safety of once-daily versus once-weekly latanoprost treatment for increased intraocular pressure. J Ocul Pharmacol Ther. 2004; 20:321-327.

Diabetes Sustenance

Diabetes Sustenance

Get All The Support And Guidance You Need To Be A Success At Dealing With Diabetes The Healthy Way. This Book Is One Of The Most Valuable Resources In The World When It Comes To Learning How Nutritional Supplements Can Control Sugar Levels.

Get My Free Ebook

Post a comment